Effect of metoclopramide on serum growth hormone levels in cirrhotic men

R. Volpi, V. Coiro, M. Salvi, G. Pelosi, P. Mancini, P. Chiodera

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Growth hormone (GH) secretory response to metoclopramide (MCP) administration was evaluated in 9 male patients with liver cirrhosis and in 6 normal controls. As expected, MCP did not modify serum GH concentrations in normal subjects. In contrast, a striking GH secretory response to MCP was observed in 5 out of 9 cirrhotics. In the other four patients serum GH levels did not show any variation after MCP. The different behavior between cirrhotic “responders” and “non responders” can not be interpreted on the basis of the medical history or the clinical and laboratory data. Three hypothesis are proposed: i) The effect of MCP could be promoted by estrogens and inhibited by androgens. ii) False neurochemical transmitters could affect dopaminergic system of some cirrhotics, allowing or inhibiting the GH response to MCP. iii) MCP could stimulate GH secretion by a serotonergic mechanism. These findings provide further evidence of a modification of the GH secretory pattern in patients with cirrhosis of the liver.

Original languageEnglish
Pages (from-to)101-105
Number of pages5
JournalJournal of Endocrinological Investigation
Volume6
Issue number2
DOIs
Publication statusPublished - 1983

Fingerprint

Metoclopramide
Growth Hormone
Serum
Liver Cirrhosis
Androgens
Estrogens

Keywords

  • 17-beta-estradiol
  • GH
  • liver cirrhosis
  • Metoclopramide
  • testosterone

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of metoclopramide on serum growth hormone levels in cirrhotic men. / Volpi, R.; Coiro, V.; Salvi, M.; Pelosi, G.; Mancini, P.; Chiodera, P.

In: Journal of Endocrinological Investigation, Vol. 6, No. 2, 1983, p. 101-105.

Research output: Contribution to journalArticle

Volpi, R. ; Coiro, V. ; Salvi, M. ; Pelosi, G. ; Mancini, P. ; Chiodera, P. / Effect of metoclopramide on serum growth hormone levels in cirrhotic men. In: Journal of Endocrinological Investigation. 1983 ; Vol. 6, No. 2. pp. 101-105.
@article{a4239379cafc4c468e7ad4807108af23,
title = "Effect of metoclopramide on serum growth hormone levels in cirrhotic men",
abstract = "Growth hormone (GH) secretory response to metoclopramide (MCP) administration was evaluated in 9 male patients with liver cirrhosis and in 6 normal controls. As expected, MCP did not modify serum GH concentrations in normal subjects. In contrast, a striking GH secretory response to MCP was observed in 5 out of 9 cirrhotics. In the other four patients serum GH levels did not show any variation after MCP. The different behavior between cirrhotic “responders” and “non responders” can not be interpreted on the basis of the medical history or the clinical and laboratory data. Three hypothesis are proposed: i) The effect of MCP could be promoted by estrogens and inhibited by androgens. ii) False neurochemical transmitters could affect dopaminergic system of some cirrhotics, allowing or inhibiting the GH response to MCP. iii) MCP could stimulate GH secretion by a serotonergic mechanism. These findings provide further evidence of a modification of the GH secretory pattern in patients with cirrhosis of the liver.",
keywords = "17-beta-estradiol, GH, liver cirrhosis, Metoclopramide, testosterone",
author = "R. Volpi and V. Coiro and M. Salvi and G. Pelosi and P. Mancini and P. Chiodera",
year = "1983",
doi = "10.1007/BF03350580",
language = "English",
volume = "6",
pages = "101--105",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "2",

}

TY - JOUR

T1 - Effect of metoclopramide on serum growth hormone levels in cirrhotic men

AU - Volpi, R.

AU - Coiro, V.

AU - Salvi, M.

AU - Pelosi, G.

AU - Mancini, P.

AU - Chiodera, P.

PY - 1983

Y1 - 1983

N2 - Growth hormone (GH) secretory response to metoclopramide (MCP) administration was evaluated in 9 male patients with liver cirrhosis and in 6 normal controls. As expected, MCP did not modify serum GH concentrations in normal subjects. In contrast, a striking GH secretory response to MCP was observed in 5 out of 9 cirrhotics. In the other four patients serum GH levels did not show any variation after MCP. The different behavior between cirrhotic “responders” and “non responders” can not be interpreted on the basis of the medical history or the clinical and laboratory data. Three hypothesis are proposed: i) The effect of MCP could be promoted by estrogens and inhibited by androgens. ii) False neurochemical transmitters could affect dopaminergic system of some cirrhotics, allowing or inhibiting the GH response to MCP. iii) MCP could stimulate GH secretion by a serotonergic mechanism. These findings provide further evidence of a modification of the GH secretory pattern in patients with cirrhosis of the liver.

AB - Growth hormone (GH) secretory response to metoclopramide (MCP) administration was evaluated in 9 male patients with liver cirrhosis and in 6 normal controls. As expected, MCP did not modify serum GH concentrations in normal subjects. In contrast, a striking GH secretory response to MCP was observed in 5 out of 9 cirrhotics. In the other four patients serum GH levels did not show any variation after MCP. The different behavior between cirrhotic “responders” and “non responders” can not be interpreted on the basis of the medical history or the clinical and laboratory data. Three hypothesis are proposed: i) The effect of MCP could be promoted by estrogens and inhibited by androgens. ii) False neurochemical transmitters could affect dopaminergic system of some cirrhotics, allowing or inhibiting the GH response to MCP. iii) MCP could stimulate GH secretion by a serotonergic mechanism. These findings provide further evidence of a modification of the GH secretory pattern in patients with cirrhosis of the liver.

KW - 17-beta-estradiol

KW - GH

KW - liver cirrhosis

KW - Metoclopramide

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=0020967420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020967420&partnerID=8YFLogxK

U2 - 10.1007/BF03350580

DO - 10.1007/BF03350580

M3 - Article

C2 - 6863846

AN - SCOPUS:0020967420

VL - 6

SP - 101

EP - 105

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 2

ER -